A look back at some of 2021’s key highlights at StaniPharm
Manufacturing of clinical GMP batches of a new vaccine adjuvant, development of innovative cannabis-based medicines …
Vaxinano partners with StaniPharm for development and production of its vaccine delivery system
“Scaling up this kind of vaccine delivery system is a crucial step and requires a strong partner” says Dr. Didier Betbeder, CEO of Vaxinano.
Cybernano and StaniPharm join forces to develop tomorrow’s health products
The complementary nature of their expertise and technologies will provide complete support for start-ups and SMEs from development through clinical trials.